StonvexLoading…
StonvexStonvexStonvexCore line items from FTHM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $129.56M | $420.48M | $329.87M | $214.56M | $93.14M |
Operating Income | Not available | $-15.58M | $-10.84M | $-6.80M | $-4.42M |
Net Income | Not available | $-20.31M | $-13.59M | $-9.24M | $-5.65M |
EPS (Diluted) | $-0.06 | $-0.72 | $-0.51 | $-0.36 | $-0.24 |
Total Assets | Not available | $78.04M | $83.24M | $80.45M | $81.02M |
Total Liabilities | Not available | $40.60M | $39.86M | $39.75M | $37.60M |
Cash & Equivalents | Not available | $5.77M | $9.76M | $4.88M | $7.98M |
Free Cash Flow OCF − CapEx | Not available | $-20.66M | $-8.71M | $-11.72M | $-5.76M |
Shares Outstanding | Not available | 32.72M | 32.08M | 28.11M | 27.59M |